Skip to main content

Table 2 Outcome Measures

From: Physio4FMD: protocol for a multicentre randomised controlled trial of specialist physiotherapy for functional motor disorder

Assessment Domain of measurement Timing
T0 T1 T2
Physical Function domain, SF36 [21] Physical disability X X X
Short Form 36 (SF36) [20] Health related quality of life X X X
Functional Mobility Scale [22] Mobility related disability X X X
Revised Illness Perception Questionnaire [23] Illness belief and understanding X X X
Hospital Anxiety and Depression Scale [24] Anxiety and Depression X X X
Clinical Global Impression Scale of Improvement (CGI-I) [25] Patient perception of change   X X
Fatigue (5-point scale) [26] Fatigue X X X
EQ-5D-5 L [27] Health Economics, to generate QALYS X X X
Client Service Receipt Inventory (CSRI) [28] Health Economics, health resource use X X X
Work Productivity & Activity Impairment Questionnaire (WPAI) [29] Employment and return to work X X X
Confidence in correctness of diagnosis of FMD (10 point scale) [30] Illness belief, confidence in diagnosis X X X
Extended Patient Health Questionnaire-15 (PHQ-15) [31, 32] Somatic symptom severity X   
Hospital Episode Statistics (HES) Health Economics, health resource use X   X
  1. Abbreviations: T0 Baseline assessment, T1 6-month assessment, T2 12-month assessment, QALYS Quality Adjusted Life Years. Pain is assessed as part of the SF36 and EQ-5D-5L questionnaires